Anti-Helicobacfer pylori effect of costunolide isolated from the stem bark of Magnolia sieboldii

Archives of Pharmacal Research

Volumn 20, Issue 3, 1997, Pages 275-279

  Park, Jong Beak ^a   Lee, Chong Kyo ^a   Park, Hee Juhn ^b  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Sangji University   (South Korea)

Author keywords

Costunolide; Growth; Helicobacter pylori; Magnolia sieboldii; Urease

Indexed keywords

EID: 0000102497     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976157     Document Type: Article

References (22)

1. Adamek, R. J., Wegener, M., Birkholz, S., Opferkuch, W., Ruhl, G. H. and Ricken, D., Modified combined omeprazole, amoxicillin therapy regimen for eradication of H. pylori. Ir. J. Med. Sci., 161 (suppl.), 90 (1992).
2. Bayerdorffer, E., Mannes, G. A., Sommer, A., Hocher, W., Weingart, J. and Hatz, R., High dose omeprazole treatment combined with amoxycillin eradicates H. pylori. Eur. J. Gastroenterol. Hepatol., 4, 697-702 (1992).
3. Chiba, N., Rao, H. V., Rademaker, J. W. and Hunt, R. H., Meta-analysis of the efficacy of antibiotic therapy of antibiotic therapy in eradicating H. pylori. Am. J. Gastroenterol., 87, 1716-1727 (1992).
4. Correa, P., A human model of gastric carcinogenesis. Cancer Res., 48, 3554-3560 (1988).
5. Glupczynski, Y., Labbe, M., Burette, A., Delmee, M., Aresani, V. and Bruck, C., Treatment failure of ofloxacin in Campylobacter pylori infection. Lancet, i, 1096 (1987).
6. Goodwin, C. S., Armstrong, J. A. and Marshall, B. J., Campylobacter pyloridis, gastritis, and peptic ulceration. J. Clin. Pathol., 39, 353-365 (1986).
7. Goodwin, C. S., Marshall, B. J., Blincow, E. D., Wilson, D. H., Blackbourne, S. and Phillips, M., Prevention of nitroimidazole resistance in Campylobacter pylori by administration of colloidal bismuth subcitrate: Clinical and in vivo studies. J. Clin. Pathol., 41, 207-210 (1988).
8. Havu, N., Enterochromaffin-like cell carcinoids of gastric mucosa in rats after lifelong inhibition of gastric secretion. Digestion, 35 (suppl 1), 42-55 (1986).
9. Lambert, T., Megraud. F., Gerbaud, G. and Couvalin, P., Helicobacter pylori is sensitive to a wide variety of antibiotics in vitro, but not in vivo. Antimicrob. Agents Chemother., 30, 510-511 (1986).
10. Leon-Barua, R., Recavarren-Arce, S., Gilman, R. H. and Berendson, R., Can eradication of Helicobacter pylori prevent gastric cancer? Drugs, 46, 341-346 (1993).
11. Malanoski, G. J., Eliopoulos, G. M., Ferraro, M. J. and Moellering, R. C., Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolides antimicrobial agents and temafloxacin. Eur. J. Clin. Microbiol., 12, 131-133 (1993).
12. Marshall, B. J., Goodwin, C. S., Warren, J. R., Murray, R., Blincow, E. D., Blackbourne, S. J., Phillips, M., Waters, T. E. and Sanderson, C. R., Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet, ii, 1437-1442 (1988).
13. Morris, A. and Nicholson, G., Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am. J. Gastroenterol., 82, 192-199 (1987).
14. Nomura, A., Stemmermann, G. N., Chyou, P. H., Kato, I., Perez-Perez, G. I. and Blaser, M. J., Helicobacter pylori infection and gastric carcinoma among Japanese americans in Hawaii. N. Engl. J. Med., 325, 1132-1136 (1991).
15. Shibata, K., Ito, Y., Kinoshita, M., Hongo, A., Mararibuchi, T. and Yasoshima, A., Effects of ecabet sodium (TA-2711) on Helicobacter pylori and its urease activity. Tanabe Seiyaku Kenkyu Houkoku, pp. 1-5 (1993).
16. Park, J.-B., Tsuchiya, M., Imamura, L. and Kobashi, K., Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor, Biol. Pharm. Bull., 18, 1053-1056 (1995).
17. Park, J.-B., Imamura, L. and Kobashi, K., Kinetic studies of Helicobacter pylori urease inhibition by a novel proton pump inhibitor, rabeprazole. Biol. Pharm. Bull., 19(2), 182-187 (1996).
18. Park, H. J., Jung, W. T., Basnet, P., Kadota, S. and Namba, T., Magnolioside, a new phenylpropanoid glycoside and costunolide, a nitric oxide synthase inhibitor, from the stem bark of Magnolia sieboldii. J. Nat. Prod, in press.
19. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N. and Sibley, R. K., Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med., 325, 1127-1131 (1991).
20. Rogan, R. P. H., Gummet, P. A., Hegarty, B., Walker, M. M., Baron, J. H. and Misiewicz, J. J., Clarithromycin and omeprazole for H. pylori (letter). Lancet, 340, 239 (1992).
21. Shimoyama, T., Fukuda, Y., Tonokatsu, Y. and Abo. H., Helicobacter pylori and gastric mucosa. J. Japan. Soc. Int. Med., 82, 286-292 (1993).
22. Tada, H., Fujioka, R., and Takayama, Y., 15-a-cetoxycostunolide from Magnolia sieboldii. Phytochemistry, 21, 458-459 (1982).